By Rob Curran
IQVIA Holdings posted 7% third-quarter net-income growth as sales of its analytic and research services to laboratories grew.
The company, which provides analytics and other services to the life-sciences industry, reported earnings for the quarter ended in September of $303 million, or $1.63 a share, up from $283 million, or $1.49 a share, a year earlier.
Stripping out one-time items, IQVIA posted adjusted earnings of $2.49 a share, ahead of the average Wall Street target of $2.44 a share, as tabulated by FactSet.
Third-quarter revenue rose 4.9% to $3.73 billion, short of the mean analyst estimate of $3.78 billion, as per FactSet.
As of Sept. 30, IQVIA’s research-and-development solutions unit had a backlog, including reimbursed expenses, of $28.8 billion, 12% above year-earlier levels
Write to Rob Curran at [email protected]
Read the full article here